Table of Contents Title of Each Class Trading Symbol(s) Name of Each Exchange On Which Registered American depositary shares (each representing four Class A ordinary shares, par value US$0.0001 per share) Class A ordinary shares, par value US$0.0001 per shares* ZEPP New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(B) OR 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT T ...

Exhibit 99.1 Zepp Health Corporation Reports Fourth Quarter and Full Year 2022 Unaudited Financial Results BEIJING, CHINA, March 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues of RMB1.1 billion (US$155.4 million); a GAAP basic and diluted net loss per share of RMB0.31 (US$0.04); and a GAAP basic and diluted net loss per ADS of RMB1.23 (US$0.18) for the fourth quarter ended December 31, 2022. Each ADS represents four Class A ordinary shares. "D ...

Zepp Health Earnings Presentation ...

Zepp Health Corporation (NYSE:ZEPP) Q4 2022 Earnings Conference Call March 21, 2023 8:00 AM ET Company Participants Grace Zhang - Director, Investor Relations Wang Huang - Chairman of Board of Directors and Chief Executive Officer Leon Deng - Chief Financial Officer Conference Call Participants Operator Hello, ladies and gentlemen. Thank you for standing by for Zepp Health Corporation's Fourth Quarter and Full-Year 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. Today' ...

Zepp Health Corporation (NYSE:ZEPP) Q3 2022 Earnings Conference Call November 21, 2022 7:30 AM ET Company Participants Grace Zhang - Director, Investor Relations Wang Huang - Chairman of Board of Directors and Chief Executive Officer Leon Deng - Chief Financial Officer Conference Call Participants Clive Cheung - Credit Suisse Operator Hello, ladies and gentlemen. Thank you for standing by for Zepp Health Corporation's Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a list ...

Zepp Health Corporation (NYSE:ZEPP) Q2 2022 Earnings Conference Call August 25, 2022 8:00 AM ET Company Participants Grace Zhang - Director, IR Wang Huang - Chairman of Board of Directors & CEO Leon Cheng Deng - CFO Conference Call Participants Operator Hello, ladies and gentlemen. Thank you for standing by for Zepp Health Corporation's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. Today's conference is being recorded. I'd now like to turn the call ove ...

Financial Data and Key Metrics Changes - The company reported Q1 2022 revenue of RMB0.8 billion, a decrease of 34% year-over-year, primarily due to reduced Mi Band 6 shipments and lower discretionary spending by consumers [7][17][21] - Gross margin for Q1 2022 was 20.1%, down from 22.5% in Q1 2021, attributed to increased freight costs and pandemic-related challenges [18][21] - Adjusted net loss for Q1 2022 was RMB75.7 million, compared to an adjusted net loss of RMB29.0 million in Q1 2021 [21] Business Line Data and Key Metrics Changes - Self-branded products contributed over 65% of total revenue in Q1 2022, indicating a shift in revenue mix towards these products [8][18] - Revenue from self-branded products in North America surged by more than 110% year-over-year, showcasing strong market performance [9] Market Data and Key Metrics Changes - The ongoing COVID-19 pandemic and geopolitical tensions have negatively impacted consumer confidence and discretionary spending, particularly in Europe and the United States [17][29] - The company anticipates a rebound in revenue for Q2 2022, projecting net revenue between RMB1.08 billion and RMB1.3 billion, compared to RMB1.84 billion in Q2 2021 [23] Company Strategy and Development Direction - The company is focusing on technological innovation in AI, health Big Data, and product portfolio expansion to capture opportunities in the healthcare services industry [14][15] - Upcoming product launches include the upgraded T-Rex 2 and new GTS and GTR series, aimed at enhancing user experience and expanding market reach [10][11] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by the pandemic and supply chain disruptions but expressed optimism about long-term growth prospects [15][17] - The company remains committed to strict cost control measures and disciplined working capital management throughout 2022 [23] Other Important Information - The company has initiated a share repurchase program, buying back $6.9 million worth of shares by March 31, 2022, reflecting confidence in its growth strategy [22] - The company is exploring options to mitigate delisting risks, including a potential second listing in Hong Kong [58] Q&A Session Summary Question: Impact of COVID in Shanghai on operations and supply chain - Management indicated that the impact of the Shanghai lockdown was relatively limited compared to Shenzhen, but it still dampened sales outlook for Q1 and Q2 [27] Question: Forecast for consumer electronics and smartwatch market - Management noted a slowdown in consumer discretionary income due to inflation but remains optimistic about the wearables market's growth [29] Question: Outlook for Q2 and revenue contribution from Xiaomi - Q2 is expected to show strong quarter-on-quarter growth, driven by new product launches, with Xiaomi's revenue contribution anticipated to increase [33][34] Question: Functional upgrades for self-branded products - The company aims to increase average selling prices (ASP) through product upgrades and enhancements in features and functionalities [38][40] Question: Expansion of Zepp OS and operational expenses - Management is focused on enhancing Zepp OS with new applications and services while planning to right-size operational expenses moving forward [44][46] Question: Growth expectations for Amazfit products - Self-branded products are expected to grow in Q2, with a gradual improvement anticipated in Q3 and Q4 due to seasonal demand [51][52] Question: Buyback strategy and delisting risk - The company plans to continue its buyback program and is monitoring delisting risks closely, considering options for a second listing [57][58] Question: Future relationship with Xiaomi - The relationship with Xiaomi remains strong, with ongoing discussions for new product lines and categories [60]